The historical rank and industry rank for PT Indofarma Tbk's Days Payable or its related term are showing as below:
ISX:INAF'
s Days Payable Range Over the Past 10 Years
Min: 72.96 Med: 114.43 Max: 727.34
Current: 583.43
During the past 13 years, PT Indofarma Tbk's highest Days Payable was 727.34. The lowest was 72.96. And the median was 114.43.
ISX:INAF's Days Payable is not ranked
in the Drug Manufacturers industry.
Industry Median: 90.69
vs ISX:INAF: 583.43
PT Indofarma Tbk's Days Payable
increased
from Dec. 2024 (456.73) to Dec. 2025 (557.46).
It may suggest that PT Indofarma Tbkdelayed paying its suppliers.
PT Indofarma Tbk Days Payable Related Terms
PT Indofarma Tbk Days Payable Historical Data
* Premium members only.
The historical data trend for PT Indofarma Tbk's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:INAF vs ZTS, VTRS, NBIX: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, PT Indofarma Tbk's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Indofarma Tbk Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, PT Indofarma Tbk's Days Payable distribution charts can be found below:
* The bar in red indicates where PT Indofarma Tbk's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PT Indofarma Tbk's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Indofarma Tbk (ISX:INAF) has a Days Payable of 557.46 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Indofarma Tbk and its competitors. This is 387% above median its historical median of 114.43. Over the past decade, PT Indofarma Tbk's Days Payable has ranged from 72.96 to 727.34.
Is PT Indofarma Tbk's Days Payable too high?
PT Indofarma Tbk's current Days Payable of 557.46 is 387% above median its 10-year median of 114.43. Over the past 10 years, this metric has ranged from a low of 72.96 to a high of 727.34. The Drug Manufacturers industry median Days Payable is 90.69. PT Indofarma Tbk's value of 557.46 is 514.7% above this industry median. Overall, PT Indofarma Tbk has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does PT Indofarma Tbk's Days Payable compare to ZTS and VTRS?
PT Indofarma Tbk's Days Payable of 557.46 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 90.69. PT Indofarma Tbk's value of 557.46 is 514.7% above this benchmark. Historically, PT Indofarma Tbk's own Days Payable has ranged from 72.96 to 727.34 over the past decade. While the company's 10-year median is 114.43 vs. the industry median of 90.69, PT Indofarma Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.69, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Indofarma Tbk's current Days Payable of 557.46 is 514.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Indofarma Tbk and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.69 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Indofarma Tbk's current Days Payable is 557.46, which is 387% above median its own 10-year median of 114.43. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Indofarma Tbk stock overvalued right now?
PT Indofarma Tbk (ISX:INAF) has a current Days Payable of 557.46. The stock's GF Value™ is Rp176.99, compared to a current price of Rp126.00 — trading 28.8% below its estimated fair value. The current Days Payable is 557.46, which is 387% above median its 10-year median of 114.43 and 514.7% above the Drug Manufacturers industry median of 90.69. PT Indofarma Tbk's overall GF Score™ is 8/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PT Indofarma Tbk (ISX:INAF), the current Days Payable is 557.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Indofarma Tbk (ISX:INAF) Overvalued in 2026?
Based on GuruFocus' analysis, PT Indofarma Tbk stock appears to be undervalued.
The current stock price of Rp126.00 is trading 28.8% below its estimated GF Value™ of Rp176.99.
Key valuation signals for ISX:INAF:
Days Payable: 557.46 (387% above median its 10-year median of 114.43)
GF Value™: Rp176.99 vs. price of Rp126.00 (28.8% below fair value)
Industry Position: 514.7% above the Drug Manufacturers median
No single metric tells the full story. See the ISX:INAF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Indofarma Tbk is a specialty and generic drug manufacturing company. The company has four business segments - Medicine, Medical Devices and others. The Medicine business segment includes drug production, marketing distribution, and sales. The Medical Device Segment includes medical devices and other products. Company generates majority revenue from the Medicine segment. The Company classifies its distribution segments based on geographic regions into six areas, namely Java, Sumatra, Kalimantan, Sulawesi, Bali dan West Nusa Tenggara (NTB),as well as the Eastern Indonesia region.
8GF Score
Get the complete analysis for ISX:INAF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:INAF has been successfully added to your 
